Found 5 matching trials
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer PHASE2 This is a prospective, single-arm, open-label,single-center, phase II study...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM PHASE2 This study is a single-arm, open-label, multicenter clinical study to evalu...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) PHASE2 This is a prospective, single-arm, open-label,multi-center, phase II study,...
Show More Location
Anyang Cancer Hospital
Learn More & Join Trial
A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma PHASE2 This is a prospective, single-arm, open-label,multi-center, phase Ib/II stu...
Show More Location
Medical Oncology,Sun Yat-sen University Cancer Center
Learn More & Join Trial